IP Library › Patent Application 17554907
Patent Application
App. No. 17/554,907

Engineered HCV E2 Immunogens and Related Vaccine Compositions

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/554,907
Abstract

The present invention provides novel engineered HCV E2 polypeptide immunogens and related vaccine compositions that display the engineered E2 polypeptides. The invention also provides methods of using such immunogens and vaccine compositions in various therapeutic applications, e.g., for preventing or treating HCV infections.

Claims (1)

1 . A modified HCV E2 ectodomain polypeptide, comprising an engineered E2 ectodomain sequence.